Drugs / Qianyangyuyin
Qianyangyuyin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT04078711 | Sep 2019 → Jun 2021 | essential hypertension | Jiangsu Province Hospital of Traditional Chinese Medicine | Unknown | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Qianyangyuyin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04078711 ↗ |
| Known as | Qianyangyuyin formula | “This study evaluates whether the traditional chinese medicine (Qianyangyuyin formula) could prevent and treat early renal injury in patients with hypertension and microalbuminuria” NCT04078711 ↗ |
| Known as | Qianyangyuyin granule | “Chinese Medicine (Qianyangyuyin granule) 20g by mouth, bid for 6 months” NCT04078711 ↗ |
| Modality | Traditional medicine (herbal / TCM) | “traditional chinese medicine (Qianyangyuyin formula)” NCT04078711 ↗ |
| Route | Oral | “Chinese Medicine (Qianyangyuyin granule) 20g by mouth, bid for 6 months” NCT04078711 ↗ |